We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$23.2B
AUM Growth
+$1.19B
Cap. Flow
-$399M
Cap. Flow %
-1.72%
Top 10 Hldgs %
11.44%
Holding
1,418
New
187
Increased
581
Reduced
380
Closed
112

Top Buys

Rank Stock Value
1
GM icon
General Motors
GM
+$53.1M
2
EXC icon
Exelon
EXC
+$52.7M
3
ORCL icon
Oracle
ORCL
+$42.5M
4
PH icon
Parker-Hannifin
PH
+$37.9M
5
RYAAY icon
Ryanair
RYAAY
+$37.8M

Top Sells

Rank Stock Value
1
FTI icon
TechnipFMC
FTI
+$67.8M
2
ECL icon
Ecolab
ECL
+$56.9M
3
FFIV icon
F5
FFIV
+$46.6M
4
RTX icon
RTX Corp
RTX
+$44.1M
5
GIS icon
General Mills
GIS
+$36.2M

Sector Composition

Rank Sector Weight
1 Technology 18.12%
2 Healthcare 16.35%
3 Financials 11.92%
4 Industrials 9.74%
5 Consumer Discretionary 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMS
851
DELISTED
Bemis
BMS
$1.48M 0.01%
+32,400
New +$1.45M
RALS
852
DELISTED
ProShares RAFI Long/Short
RALS
$1.47M 0.01%
39,020
IJK icon
853
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.4B
$1.47M 0.01%
29,040
+20,800
+252% +$1.03M
LOPE icon
854
Grand Canyon Education
LOPE
$3.99B
$1.46M 0.01%
+16,100
New +$1.29M
TTC icon
855
Toro Company
TTC
$8.75B
$1.46M 0.01%
23,500
-12,900
-35% -$864K
MCRN
856
DELISTED
Milacron Holdings Corp.
MCRN
$1.46M 0.01%
86,400
+22,600
+35% +$384K
INFY icon
857
Infosys
INFY
$45.4B
$1.45M 0.01%
198,826
+127,772
+180% +$968K
BG icon
858
Bunge Global
BG
$22.9B
$1.45M 0.01%
20,800
-68,700
-77% -$5.2M
WSR
859
DELISTED
Whitestone REIT
WSR
$1.44M 0.01%
110,100
+15,100
+16% +$193K
ICPT
860
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.43M 0.01%
24,648
-64,021
-72% -$6.9M
RDN icon
861
Radian Group
RDN
$4.64B
$1.42M 0.01%
+76,200
New +$1.32M
EZPW icon
862
Ezcorp Inc
EZPW
$1.87B
$1.42M 0.01%
149,593
+12,400
+9% +$108K
MKTX icon
863
MarketAxess Holdings
MKTX
$5.75B
$1.42M 0.01%
7,700
-8,900
-54% -$1.7M
FXE icon
864
Invesco CurrencyShares Euro Currency Trust
FXE
$357M
$1.41M 0.01%
12,342
CMRX
865
DELISTED
Chimerix, Inc.
CMRX
$1.4M 0.01%
266,673
+8,100
+3% +$39.9K
CLDX icon
866
Celldex Therapeutics
CLDX
$3.03B
$1.4M 0.01%
32,590
+7
+0% +$262
APA icon
867
APA Corp
APA
$15.6B
$1.4M 0.01%
30,470
-1,565
-5% -$69K
KEM
868
DELISTED
KEMET Corporation
KEM
$1.4M 0.01%
65,999
+44,099
+201% +$834K
TNAV
869
DELISTED
Telenav Inc.
TNAV
$1.39M 0.01%
219,080
+7,900
+4% +$54.9K
VTIP icon
870
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$20.5B
$1.38M 0.01%
27,996
+500
+2% +$24.7K
TTPH
871
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$1.38M 0.01%
10,097
+9,172
+992% +$1.23M
UVE icon
872
Universal Insurance Holdings
UVE
$1.23B
$1.37M 0.01%
59,700
+11,300
+23% +$256K
PFG icon
873
Principal Financial Group
PFG
$25.4B
$1.37M 0.01%
21,294
+15,829
+290% +$1.02M
LNC icon
874
Lincoln National
LNC
$8.38B
$1.36M 0.01%
+18,500
New +$1.31M
KEY icon
875
KeyCorp
KEY
$22.8B
$1.33M 0.01%
70,719
+5,800
+9% +$105K

Similar funds

Axa's Q3 2017 Portfolio in Review

As of Q3 2017, Axa held 1,418 positions worth $23.2B, up 5.4% from $22B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Axa's Q3 2017 filing shows 187 new, 581 increased, 380 reduced and 112 closed positions. Its largest new stake was Ryanair: 836,448 shares worth $35.3M. The largest sale was TechnipFMC, an estimated $67.8M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q3 2017 buy was Ryanair: 836,448 shares worth $35.3M.
  • Axa added most to General Motors in Q3 2017, an estimated $53.1M increase.
  • Axa's biggest Q3 2017 reduction was TechnipFMC, cutting an estimated $67.8M.
  • Axa fully exited F5 in Q3 2017, selling an estimated $46.6M.
  • Axa's ten largest holdings make up 11% of its $23.2B portfolio in Q3 2017.
  • Axa opened 187 new positions and closed 112 in Q3 2017.
  • Axa's portfolio value rose 5.4% quarter-over-quarter to $23.2B.

Based on Axa's 13F filing for Q3 2017, filed 13 Nov 2017.